Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Variants in human papillomavirus receptor and associated genes are associated with type-specific HPV infection and lesion progression of the cervix.

Zou J, Cao Z, Zhang J, Chen T, Yang S, Huang Y, Hong D, Li Y, Chen X, Wang X, Cheng X, Lu W, Xie X.

Oncotarget. 2016 Jun 28;7(26):40135-40147. doi: 10.18632/oncotarget.9510.

2.
3.

HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions.

Mariani L, Sandri MT, Preti M, Origoni M, Costa S, Cristoforoni P, Bottari F, Sideri M.

J Cancer. 2016 Jan 1;7(1):107-14. doi: 10.7150/jca.13503. Review.

4.

Increased RIPK4 expression is associated with progression and poor prognosis in cervical squamous cell carcinoma patients.

Liu DQ, Li FF, Zhang JB, Zhou TJ, Xue WQ, Zheng XH, Chen YB, Liao XY, Zhang L, Zhang SD, Hu YZ, Jia WH.

Sci Rep. 2015 Jul 7;5:11955. doi: 10.1038/srep11955.

5.

Psychosocial barriers to follow-up adherence after an abnormal cervical cytology test result among low-income, inner-city women.

Hui SK, Miller SM, Wen KY, Fang Z, Li T, Buzaglo J, Hernandez E.

J Prim Care Community Health. 2014 Oct;5(4):234-41. doi: 10.1177/2150131914529307.

6.

Cervical cytology screening among low-income, minority adolescents in New York City following the 2009 ACOG guidelines.

Tsui J, Hofstetter AM, Soren K.

Prev Med. 2014 Jun;63:81-6. doi: 10.1016/j.ypmed.2014.03.010.

7.

Three-year risk of cervical precancer and cancer after the detection of low-risk human papillomavirus genotypes targeted by a commercial test.

Castle PE, Hunt WC, Langsfeld E, Wheeler CM; New Mexico HPV Pap Registry Steering Committee..

Obstet Gynecol. 2014 Jan;123(1):49-56. doi: 10.1097/AOG.0000000000000013.

8.

Cervical excisional treatment of young women: a population-based study.

Kinney W, Hunt WC, Dinkelspiel H, Robertson M, Cuzick J, Wheeler CM; New Mexico HPV Pap Registry Steering Committee..

Gynecol Oncol. 2014 Mar;132(3):628-35. doi: 10.1016/j.ygyno.2013.12.037.

9.

Value of human papillomavirus typing for detection of anal cytological abnormalities.

Maia LB, Marinho LC, Barbosa TW, Velasco LF, Costa PG, Carneiro FP, de Oliveira PG.

Indian J Sex Transm Dis. 2013 Jul;34(2):102-6. doi: 10.4103/0253-7184.120540.

10.

Tailored telephone counseling to improve adherence to follow-up regimens after an abnormal pap smear among minority, underserved women.

Miller SM, Hui SK, Wen KY, Scarpato J, Zhu F, Buzaglo J, Hernandez EE.

Patient Educ Couns. 2013 Dec;93(3):488-95. doi: 10.1016/j.pec.2013.08.008.

11.

Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less.

Katki HA, Gage JC, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Kinney WK.

J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S69-77. doi: 10.1097/LGT.0b013e31828543b1.

12.

Comparative risk of high-grade histopathology diagnosis after a CIN 1 finding in endocervical curettage versus cervical biopsy.

Gage JC, Duggan MA, Nation JG, Gao S, Castle PE.

J Low Genit Tract Dis. 2013 Apr;17(2):137-41. doi: 10.1097/LGT.0b013e3182630c41.

13.
14.

Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix.

Waxman AG, Chelmow D, Darragh TM, Lawson H, Moscicki AB.

Obstet Gynecol. 2012 Dec;120(6):1465-71. doi: http://10.1097/AOG.0b013e31827001d5.

15.

Early human papillomavirus testing predicts residual/recurrent disease after LEEP.

Ryu A, Nam K, Kwak J, Kim J, Jeon S.

J Gynecol Oncol. 2012 Oct;23(4):217-25. doi: 10.3802/jgo.2012.23.4.217.

16.

Human papillomavirus: what every provider should know.

Erickson BK, Alvarez RD, Huh WK.

Am J Obstet Gynecol. 2013 Mar;208(3):169-75. doi: 10.1016/j.ajog.2012.09.007. Review.

17.
18.

Adherence to conservative management recommendations for abnormal pap test results in adolescents.

Perkins RB, Jorgensen JR, McCoy ME, Bak SM, Battaglia TA, Freund KM.

Obstet Gynecol. 2012 Jun;119(6):1157-63. doi: 10.1097/AOG.0b013e31824e9f2f.

19.

Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data.

Joura EA, Garland SM, Paavonen J, Ferris DG, Perez G, Ault KA, Huh WK, Sings HL, James MK, Haupt RM; FUTURE I and II Study Group..

BMJ. 2012 Mar 27;344:e1401. doi: 10.1136/bmj.e1401.

20.

The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy.

Castle PE, Gage JC, Wheeler CM, Schiffman M.

Obstet Gynecol. 2011 Dec;118(6):1222-9. doi: 10.1097/AOG.0b013e318237caf4.

Items per page

Supplemental Content

Support Center